Oncology Pharma Inc. (OTCMKTS:ONPH) Short Interest Update
Oncology Pharma Inc. (OTCMKTS:ONPH) Short Interest Update
Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 22,900 shares, a drop of 24.7% from the January 31st total of 30,400 shares. Based on an average daily volume of 98,900 shares, the days-to-cover ratio is presently 0.2 days.
Oncology Pharma Stock Performance
OTCMKTS ONPH remained flat at $0.34 during mid-day trading on Thursday. 25,501 shares of the company traded hands, compared to its average volume of 52,361. The firm's fifty day moving average price is $0.39 and its 200 day moving average price is $0.64. Oncology Pharma has a twelve month low of $0.32 and a twelve month high of $4.40.
Get Oncology Pharma alerts:Oncology Pharma Company Profile
(Get Rating)
Oncology Pharma, Inc engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
See Also
- Get a free copy of the StockNews.com research report on Oncology Pharma (ONPH)
- Hormel Hits 2-Year Low, And The Dip Gets Bought
- Here's Why Ross Could Soon Be Hitting All Time Highs
- The Bottom Is In For Salesforce.com
- It's Time For A Fresh Look At The Kroger Co.
- West Fraser's Earnings Scream Timber, Outlook Says Buy
Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
Oncology Pharma Inc. (OTCMKTS:ONPH – Get Rating) was the target of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 22,900 shares, a drop of 24.7% from the January 31st total of 30,400 shares. Based on an average daily volume of 98,900 shares, the days-to-cover ratio is presently 0.2 days.
Oncology Pharma Inc.（OTCMKTS: ONPH — 獲取評級）是2月份空頭利息大幅下降的目標。截至2月15日，空頭利息總額爲22,900股，較1月31日的30,400股下降了24.7％。根據98,900股的平均每日交易量，目前的覆蓋天數爲0.2天。
Oncology Pharma Stock Performance
腫瘤製藥股票表現
OTCMKTS ONPH remained flat at $0.34 during mid-day trading on Thursday. 25,501 shares of the company traded hands, compared to its average volume of 52,361. The firm's fifty day moving average price is $0.39 and its 200 day moving average price is $0.64. Oncology Pharma has a twelve month low of $0.32 and a twelve month high of $4.40.
在週四午盤交易中，OTCMKTS ONPH持平至0.34美元。該公司共有25,501股交易手，而平均交易量爲52,361股。該公司的五十天移動平均價格爲0.39美元，其200天移動平均線價格爲0.64美元。Oncology Pharma的十二個月低點爲0.32美元，爲十二個月高點4.40美元。
Oncology Pharma Company Profile
腫瘤製藥公司簡介
(Get Rating)
（獲取評級）
Oncology Pharma, Inc engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
Oncology Pharma, Inc從事療法的開發、製造和商業化。該公司由馬塞爾·範·海瑟維克於1993年3月26日創立，總部位於加利福尼亞州舊金山。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Oncology Pharma (ONPH)
- Hormel Hits 2-Year Low, And The Dip Gets Bought
- Here's Why Ross Could Soon Be Hitting All Time Highs
- The Bottom Is In For Salesforce.com
- It's Time For A Fresh Look At The Kroger Co.
- West Fraser's Earnings Scream Timber, Outlook Says Buy
- 免費獲取 StockNews.com 關於腫瘤製藥 (ONPH) 的研究報告的副本
- 荷美爾觸及2年低點，跌幅被買入
- 這就是羅斯可能很快創下歷史新高的原因
- Salesforce.com 已經觸底了
- 是時候重新審視克羅格公司了
- West Fraser 的收益令人震驚，Outlook 表示買入
Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
接收腫瘤製藥日報的新聞和收視率 -在下面輸入您的電子郵件地址，以通過Marketbeat.com的免費每日電子郵件時事通訊接收Oncology Pharma及相關公司最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧